Amanote Research
Register
Sign In
P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1168
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
L. Yong
S. Kuo
P. Yang
P. Huang
M. Lin
K. Chen
J. Lee
Publisher
Elsevier BV
Related search
Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-44 Prognostic Value of TP53 Hot Exon Mutation in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
P1.17-14 Outcomes of Hypofractionated Radiation Therapy (HFRT) With Concurrent Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prognostic Value of White Blood Cells Detected for the First Time After Adjuvant Chemotherapy in Primary Operable Non-Small Cell Lung Cancer
Technology in Cancer Research and Treatment
Medicine
Cancer Research
Oncology
P2.01-40 Prognostic Importance of Sarcopeni and Inflammatory Statements in Stage III Non Small Cell Lung Carcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Combining Antiangiogenic Therapy With Neoadjuvant Chemotherapy Increases Treatment Efficacy in Stage IIIA (N2) Non-Small Cell Lung Cancer Without Increasing Adverse Effects
Oncotarget
Oncology
P3.01-31 Prognostic Factors in Patients With Resected Pathological N2 Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary